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Sialic acidﬁeld's major ﬁndings related to the characterization of polyomavirus structures
and to the characterization of virus receptors and mechanisms of host cell invasion. The four members of the
family that have received the most attention in this regard are the mouse polyomavirus (mPyV), the monkey
polyomavirus SV40, and the two human polyomaviruses, JCV and BKV. The structures of both the mPyV and
SV40 alone and in complex with receptor fragments have been solved to high resolution. The majority of
polyomaviruses recognize terminal sialic acid in either an α2,3 linkage or an α2,6 linkage to the underlying
galactose. Studies on virus structure, receptor utilization and mechanisms of entry have led to new insights
into how these viruses interact in an active way with cells to ensure the nuclear delivery and expression of
their genomes. Critical work on virus entry has led to the discovery of a pH neutral endocytic compartment
that accepts cargo from caveolae and to novel roles for endoplasmic reticulum (ER) associated factors in virus
uncoating and penetration of ER membranes. This review will summarize the major ﬁndings and compare
and contrast the mechanisms used by these viruses to infect cells.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe family Polyomaviridae are classiﬁed as group 1 viruses in the
Baltimore classiﬁcation scheme as they contain double stranded DNA
genomes. There is a single genus designation within the virus family
(Polyomavirus) and this genus contains 14 different species that infect
at least 8 different mammalian species. In addition to containing
dsDNA genomes all members of this virus family are non-enveloped.
The members of the family typically display restricted species and cell
type speciﬁcity for lytic infection but many can induce the
transformation of cells that do not support lytic infection. Host cell
and species-speciﬁc transcription and replication factors contribute
signiﬁcantly to the restricted speciﬁcity displayed by these viruses
(Feigenbaum et al., 1987; Lynch and Frisque, 1991; Tada et al., 1989).
Virus-receptor interactions are also known to contribute to cell type
speciﬁcity andmore importantly to pathogenesis in vivo (Caruso et al.,
2007; Chen and Atwood, 2002; Dubensky et al., 1991; Freund et al.,
1991a; Freund et al., 1991b; Fried et al., 1981). Like many other virus
families the polyomaviruses use multiple and often distinct receptorsat Interfakultäres Institut für
D-72076 Tübingen, Germany.
logy and Biochemistry, Brown
1971.
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l rights reserved.and entry mechanisms to infect cells. At high enough multiplicities
many of these viruses can infect cells using alternative often poorly
described mechanisms. The structures of two major members of the
family have been solved in complex with receptor fragments and this
has given insight into how these viruses recognize host cells
(Liddington et al., 1991; Neu et al., 2008; Stehle and Harrison, 1997;
Stehle et al., 1994). A major area of current investigation by several
labs is focused on understanding the intracellular trafﬁcking of
polyomaviruses in host cells and the mechanisms involved in virus
uncoating and delivery of the dsDNA genomes to the nucleus. This
paper will overview the ﬁeld of virus structure and entry from its
beginnings to the present. The focus will be on the mouse
polyomavirus, on SV40, and on the twomajor human polyomaviruses,
JCV and BKV.
Virus discovery
The mouse polyomavirus (mPyV) was ﬁrst described by Ludwig
Gross in 1953 in his studies on the transmission of mouse leukemias
(Gross, 1953). He noticed that mice inoculated with cell free extracts
from leukemias were capable of not only transmitting leukemia to
naïve animals but that some of the animals also developed parotid
tumors. In classic experiments he found that the “parotid” agent could
be distinguished from the mouse leukemia virus by ﬁltration. Filters
with larger pore sizes allowed both viruses to pass but ﬁlters of
smaller pore size selectively trapped the leukemia agent indicating
390 Minireviewthat the parotid agent was smaller than the leukemia virus. In the mid
to late 1950s Stewart and Eddy followed up on these observations and
found that the “parotid” agent was capable of inducing many different
types of tumors when inoculated into mice and renamed the virus
“poly”oma from the Greek for many tumors (Eddy et al., 1958; Stewart
et al., 1958).
SV40 was discovered as a contaminant of formalin inactivated
polioviruses that were grown in Rhesus monkey kidney cells (Sweet
and Hilleman,1960). The subsequent characterization of this virus as a
papovavirus capable of transforming cells in vitro and inducing
tumors in experimental animals was a cause for great concern as
several hundred thousand individuals were inoculated with the
contaminated vaccine (Girardi et al., 1962). This launched several
decades of intensive research on SV40. This work on SV40 led to the
discovery of many important cellular processes described elsewhere
in this issue of the journal.
JCV and BKVwere both identiﬁed in 1971 from immunosuppressed
patients. JCV was islolated in human fetal brain cultures following
transfer from the brain of a patient with PML (Padgett et al., 1971). It
was given the name JCV after the patient's initials. BKV was isolated in
VERO cells (African green monkey kidney cells) from the urine of a
renal transplant recipient (Gardner et al., 1971). It was also named
after the initials of the patient from whom it was isolated.
Virus–host cell interactions
Mouse polyomavirus
The ﬁrst studies of polyomavirus host-cell interactions followed
closely behind their initial discovery and isolation in mammalian
tissue culture. Shortly after virus cultivation a number of groups
began examining the interaction of mPyV with host cells using both
biochemical and electron microscopy (EM) techniques. Infection of
cells by the mPyV was envisioned as a multi-step process that
included virus adsorption, virus penetration, and virus uncoating.
Morphological studies documented that whole virions were taken
up into cells by phagocytosis as membrane bound single particles
and membrane bound aggregates (Mattern et al., 1966; Mattern et
al., 1967). Virus particles then appeared between the nuclear
membrane but viral particles were not seen within the nucleus at
these early times. This led to the conclusion that viral particles
uncoat between the nuclear membranes and before they reach theFig. 1. Early model of polyomavirus attachment, penetration, and nuclear entry. Open virion
that presumably lead to degradation. Closed virions represent infectious particles and unlike
found in large tubular structures that likely represent the pinching off of these structures f
Modiﬁed from information in Mackay and Consigli, 1976 and Maul et al., 1978.nucleus (as we will see later this interpretation is largely correct
with some minor modiﬁcations).
In the early 1970s it became apparent that polyomavirus prepa-
rations contained signiﬁcant numbers of defective interfering parti-
cles. The ability to plaque purify virus preparations allowed for an
enrichment of infectious virions and for their separation from empty
capsids by density gradient centrifugation. Detailed analyses of these
individual populations by EM indicated that empty capsids and light
populations of virions (pseudovirions) were endocytosed by two
different pathways (Bolen and Consigli, 1979; Mackay and Consigli,
1976). Virions and pseudovirions were predominantly endocytosed as
single membrane-bound particles that trafﬁcked intact to the nucleus.
Empty capsids were endocytosed as aggregates into large vesicles that
later appeared to fuse with lysosomes, apparently destined for
degradation. A model was developed showing these two opposing
endocytic routes in the cell (Fig. 1).
The fact that virions and pseudovirions behaved differently than
empty capsids led Consigli and colleagues to carefully examine the
viral particles for subtle differences in protein composition. Using
radiolabeled preparations they identiﬁed six species of VP1 (A–F) by
isolelectric focusing (Bolen et al., 1981). Only virions and pseudovir-
ions were found to contain species E leading the group to hypothesize
that species E was critical for delivering virions and pseudovirions to
the nucleus. Antibodies raised against virions that were found to be
neutralizing speciﬁcally recognized species D, E, and F supporting this
hypothesis (Bolen et al., 1981). The group then went on to attempt
isolation of cellular receptors for mPyV by preparing anti-idiotypic
antibodies to VP1 (Marriott and Consigli, 1985; Marriott et al., 1987).
These antibodies blocked infection and pulled down several proteins
associated with cell surfaces. The identities of these proteins were
never determined and none were found to act as receptors for the
virus.
The mPyV and the two human polyomaviruses, JCV and BKV are
known to require sialic acid for binding to host cells as “receptor
destroying enzyme” or neuraminidase inhibits the viruses' ability to
agglutinate red blood cells and to infect cells (Table 1). SV40 was
thought not to attach to sialic acid as it did not agglutinate red blood
cells and neuraminidase treatment of host cells did not reduce
infectivity (Clayson and Compans, 1989). However, SV40 does attach
to a sialic acid containing receptor, ganglioside GM1, with sialic acid
being the major contact point, but the narrow speciﬁcity of SV40 for
GM1 prevents it from binding to carbohydrates on red blood cells. Ins represent empty capsids that are found to be internalized in large endosomal vesicles
empty capsids these are internalized into monopinocytotic vesicles. Some virions were
rom caveosomes described years later by Helenius (see text for detailed descriptions).
Table 1
Receptors and entry pathways utilized by polyomaviruses
BKV JCV SV40 mPyV
Receptors α2,3-linked sialic acid Terminal α2,3 or
α(2,6)-linked sialic acid
Sialic acid on GM1 α2,3-linked sialic acid
GD1b, GT1b GT1b GM1 GD1a, GT1b
Co-receptors Unknown Serotonin receptor (5HT-2a) MHC class I α4β1 integrin
Entry mechanism Caveolae-mediated Clathrin-dependent Primarily caveolae-mediated Caveolae dependent and
independent mechanisms
Cytoplasmic
transport
Vesicles localize to ER Early endosomes to caveosomes Fuse into caveosome and
localize to ER
Endosome with caveolin-1
localizes to ER
ER, endoplasmic reticulum.
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with SV40 does not cleave the sialic acid off GM1 so that it leaves the
receptor intact (Miller-Podraza et al., 1982). It can even cleave sialic
acid off higher order gangliosides to yield GM1. Therefore, neurami-
nidase treatment did not reduce SV40 receptors on cells and did not
abolish infectivity. Early reports in the mPyV system suggested that
the sialic acid interactions were largely due to non-speciﬁc electro-
static interactions between the virus and these negatively charged cell
surface carbohydrates. Subsequent studies by the Paulson group
proved this hypothesis to be incorrect (Cahan and Paulson, 1980; Fried
et al., 1981). They showed that mPyV recognized speciﬁc sialic acid
structures on red blood cells and on mouse cells containing α2,3-
linked sialic acid. Small and large plaque binding variants of mouse
polyomavirus were subsequently shown to have different afﬁnities for
a branched compound that additionally contained a second, α2,6-
linked sialic acid. Large plaque strains bound less well to the branched
structure than did the small plaque strain (Cahan et al., 1983). These
data correlated well with an earlier study showing that small plaque
viruses adsorb to cells much better than the large plaque strains
(Diamond and Crawford, 1964).
In more recent studies from the Benjamin lab these differences
were exploited and the plaque phenotypes genetically mapped to a
single amino acid difference in the major capsid protein of the virusFig. 2. General model of infectious entry pathways utilized by polyomaviruses. JCV is unique i
early endosomes and then to caveosomes. BKV, SV40, and mPyV are reported to use caveol
mPyV can also use non-caveolar but cholesterol dependent mechanisms of entry to access the
and mPyV trafﬁc to the endoplasmic reticulum in tubular structures that bud off the ER mem
Adapted from Marsh and Helenius, 1989.(Freund et al., 1991b). More importantly these differences in plaque
behavior directly translated to their behavior in mouse models of
infection (Dubensky et al., 1991; Freund et al., 1991a). The large plaque
strain spread more efﬁciently in mice and induced a higher frequency
of tumors and the tumors were more widespread than those caused
by the small plaque strains. This led to the hypothesis that the
branched structures act as pseudoreceptors that are bound by the
virus, but do not result in productive infection. The analysis of virus–
host cell interactions was thus important for understanding spread
and pathogenicity of this group of viruses and generated increased
interest in identifying speciﬁc receptors.
The Benjamin lab also attempted to isolate speciﬁc proteinaceous
receptors for mPyV by producing and screening several thousand
mononclonal antibodies raised against permissive mouse cell surfaces
(Bauer et al., 1999). None of the antibodies were found capable of
inhibiting infection leading them to conclude that no single molecule
on the surface of the cells served as a speciﬁc receptor.
The ﬁrst hint of a proteinaceous receptor for mPyV came from
studies in the Amati lab where antibodies directed against natural
integrin ligands as well as antibodies directed at α4β1 integrin
inhibited a post-attachment step in infection (Caruso et al., 2003)
(Table 1). This was found to be mediated by an LDV integrin binding
motif present in mPyV VP1 as a speciﬁc mutation in this motif reducesn that it initially enters cells by clathrin dependent endocytosis. The virus then trafﬁcs to
ae dependent mechanisms of entry that trafﬁc these viruses to caveosomes. SV40 and
caveosome and themechanism used depends on cell type. Once in the caveosome SV40
brane. It is presumed that JCV and BKV use the same pathway but data on this is lacking.
392 Minireviewinfectivity (Caruso et al., 2007). Interestingly, when inoculated into
newbornmice, themPyV displays an altered pattern of infectionwhen
compared towild type (Caruso et al., 2007). Previous receptor hunting
experiments described above would have missed this ligand as the
virus apparently needs to undergo a conformational change after
binding to sialic acid that then allows it to bind to the integrin
receptors as a second step in the entry process. It is not certain
whether infection of all cells requires this second step but it is clear
that in some cases it is utilized. However, the LDV motif is buried
under the receptor binding loops deep within VP1, and the mutation
could have affected the structure of the binding site indirectly.
Recent studies from both the Benjamin and Rapoport groups
clearly delineated a role for the gangliosides GD1a and GT1b in mPyV
infection and for the ganglioside GM1 in SV40 infection (Gilbert and
Benjamin, 2004; Gilbert et al., 2005; Tsai et al., 2003) (Table 1). The
Rapoport group used sucrose ﬂotation assays to initially ask whether
mPyV would ﬂoat when mixed with plasma membrane preparations
from human erythrocytes, from bacterial membranes or from yeast
membranes. They found that when mPyV was incubated with buffer
or with either bacterial or yeast membranes the virus fractionated in
the bottom third of the gradient. When mPyV was incubated with
plasma membrane from human erythrocytes the virus ﬂoated to the
top of the gradient indicating an association with plasma membrane
lipids. Upon treatment of the plasma membranes with neuraminidase
the virus failed to ﬂoat and fractionated at the bottom of the gradient.Fig. 3.Mechanisms used by polyomaviruses to exit the ER and target their genomes to the nuc
formally proven that JCV and BKV do the same. Once in the ER mPyV utilizes the unusual PD
lead to cleavage of the C-terminal arm of VP1 allowing the particle to bind to lipid membra
canonical ER oxidoreductases, PDI, and ERp57, to unravel 12 of the vertex pentamers in the v
degradation (ERAD) pathway (Derlin 1 and SelL1) to exit the ER. The viruses encounter a low
disassembled the viral protein–mini-chromosome complex is transported across an intact nSpeciﬁc gangliosides were then tested for their ability to interact with
polyomaviruses. mPyV only ﬂoated to the top of the gradient in the
presence of GD1 and GT1b, and SV40 only ﬂoated to the top of the
gradient in presence of GM1. The group then showed that rat cells
cell deﬁcient in complex ganglioside biosynthesis are poorly suscep-
tible to mPyV and SV40 infection. However, when preincubated with
GD1a or GT1b they become highly susceptible to mPyV and GM1
restores susceptibility to SV40. Fluorescent co-localization studies
indicated that the virus trafﬁcs directly to the ER with the gangliosides
(Fig. 2).
This mode of internalization is strikingly similar to the one used by
ER directed bacterial toxins of the AB5 family, such as cholera toxin,
whose known receptors are gangliosides. In the case of the toxins,
however, trafﬁcking proceeds through the Golgi. Thus far there is no
evidence that mPyV or SV40 trafﬁcs through the Golgi and instead
they appear to trafﬁc through caveosomes to eventually reach the ER
where partial uncoating of the viruses take place. Once the mPyV
reaches the ER it takes advantage of an unusual member of the protein
disulﬁde isomerase family, ERp29 (Magnuson et al., 2005) (Fig. 2). PDI
family members are oxidoreductases that contain one to several CXXC
motifs in their thioredoxin domains (Hebert andMolinari, 2007). They
function to both reduce and oxidize disulphide bonds in newly
synthesized proteins. They also isomerize disulphide bonds assisting
in the formation of native protein structures. ERp29 is structurally
related to PDI proteins but it contains only a single cysteine in itsleus. Themouse polyomavirus and SV40 both trafﬁc to the ER and it is presumed but not
I family member, ERp29 to induce a conformational change in its coat protein. This may
nes. The ER retrotranslocation protein Derlin 2 is involved in ER exit. SV40 utilizes the
irus shell. This unfolded protein is then recognized by components of the ER associated
calcium environment in the cytosol that may allow for their further disassembly. Once
uclear pore for genome delivery to the nucleus.
393Minireviewentire sequence and hence can only function in the isomerization
reaction. A role for ERp29 in normal cellular functions has not been
established. The Tsai group identiﬁed ERp29 as the PDI familymember
responsible for inducing a conformational change in mPyV VP1 that
exposes a trypsin sensitive site in VP1 (Tsai et al., 2003) (Fig. 3). This
conformational change is thought to result in the proteolytic cleavage
of the C-terminal arm of VP1. As the C-terminal arm is involved in
linking and stabilizing pentamer–pentamer interactions its cleavage
would be predicted to destabilize the particle. The cleavage also led to
the formation of a virion particle capable of binding and penetrating a
lipid bilayer. This is predicted to facilitate the release of a partially
disassembled and de-stabilized virion into the cytosol where nuclear
localization signals in the VP1 protein could direct it across the nuclear
pore (Fig. 3). Work from the Benjamin lab identiﬁed another ER
protein as being critical for mPyV infection. In this study shRNAs
directed at a protein involved in retrotranslocation of misfolded
proteins out of the ER, Derlin 2, was found to signiﬁcantly impair
mPyV infection (Lilley et al., 2006) (Fig. 3). In related work Helenius
and colleagues found that several ER associated factors played critical
roles in SV40 disassembly and release from the ER (Schelhaas et al.,
2007) (Fig. 3). Inhibition of PDI, ERp57, and Derlin 1 by siRNA
knockdown all inhibited SV40 infection of cells. Knockdown of ERp29,
calnexin or calreticulin had no effect on SV40 infection. They found
that ERp57 uncoupled the 12 ﬁve-coordinated VP1 pentamers of SV40.
This led to complete uncoating in the presence of EGTA, which
removes the calcium ions that help to anchor the incoming C-terminal
arms. The group also demonstrated a role for Derlin 1 and SelL1, two
proteins involved in the ERAD retrotranslocation pathway in SV40
infection (Fig. 3). The model that emerges is one where the virion is
delivered to the ER where it is recognized by components of the ER
quality control machinery and is subjected to PDI related proteins that
isomerize speciﬁc disulﬁde bonds involved in linking pentamers
together within the capsid. The destabilized virion is then recognized
essentially as a misfolded protein and is retrotranslocated out of the
ER where it encounters a low calcium environment in the cytosol.
Calcium is critical for viral particle stability and low levels of calcium
in the cytosol likely contribute to further destabilization of the virion.
Exposure of nuclearlocalization signals in viral capsid proteins that
likely remain bound to the mini-chromosome then transport the
mini-chromosome across the nuclear pore (Ishii et al., 1996;
Kasamatsu and Nakanishi, 1998; Nakanishi et al., 1996; Yamada and
Kasamatsu, 1993) (Fig. 3). It thus appears that at least two
polyomaviruses, mPyV and SV40, utilize ER associated degradative
pathways for uncoating.
SV40
Studies on SV40 entry mechanisms proceeded similarly and often
in parallel with the work on mPyV described above. Hummeler and
colleagues followed the fate of SV40 particles in cells by electron
microscopy (Hummeler et al., 1970). They describe the majority of
particles becoming rapidly enveloped at the plasma membrane into
monopinocytotic vesicles. SV40 particles could be seen as early as 1 h
post-infection in the nucleus. Maul and colleagues subsequently
investigated the uptake and trafﬁcking of SV40 in permissive and non-
permissive cells (Maul et al., 1978). No qualitative differences were
seen between the two cell types indicating that these steps did not
restrict virus infection of cells. Their ﬁndings were very similar to
those of Hummeler but they described several intervening steps in the
entry process including a prominent association of viral particles in
tubular membrane structures and of particles associated with rough
ER. They did observe particles in the nucleus but these particles were
not surrounded by membrane. They proposed a model where the
entry of SV40 followed a series of membrane fusion and ﬁssion steps
eventually liberating virions in the nucleus for uncoating. As they
observed some free virions in the cytoplasm and some in the nucleusthey proposed that the nucleus must contain an uncoating enzyme
not present in the cytosol. As it turns out it appears that the ER
contains the necessary factors for uncoating. The tubular structures
they observed were likely virions pinching off in large tubular struc-
tures from caveosomes as described by Helenius many years later
(Pelkmans et al., 2001). These tubular vesicles are transported to the
ER in amicrotubual dependentmanner (Pelkmans et al., 2001) (Fig. 2).
We now appreciate that most if not all polyomaviruses are trafﬁcked
to the ER where uncoating occurs or at least begins.
The single virus particles being enclosed in membranous vesicles
at the plasma membrane described in the Maul paper were the ﬁrst
demonstration of caveolae which were only later appreciated as
being critical organelles for SV40 entry into cells (Anderson et al.,
1996) (Fig. 2). Caveolae are membrane microdomains rich in
sphingolipids and signaling molecules. SV40 exploits these domains
most likely by virtue of its interaction with the ganglioside GM1.
Entry is relatively slow and proceeds in a pH neutral manner from
caveolae to caveosomes to the ER (Pelkmans et al., 2001). In addition
to the ganglioside GM1, SV40 was also reported to use MHC class I
molecules to infect permissive cells (Atwood and Norkin, 1989) (Table
1). The virus can infect some cells lacking MHC I and in these cases
GM1 is the principle receptor although infection is inefﬁcient. The
relationship between these receptors remains unclear.
JCV and BKV
The human polyomaviruses, JCV and BKV were discovered more
recently and difﬁculties in isolating receptors for the mouse
polyomavirus and SV40 probably precluded any interest in pursuing
this with JCV and BKV as both are somewhat more difﬁcult to
propagate than SV40 or the mouse polyomavirus. With the introduc-
tion of new tools and techniques these issues have begun to be
explored by several groups. Both of the human polyomaviruses
require sialic acid to infect cells. JCV can use either an α2,3- or an
α2,6-linked sialic acid to infect permissive glial cells (Dugan et al.,
2007; Liu et al., 1998) and a ganglioside (GT1b) may also be involved
(Komagome et al., 2002) (Table 1). BKV uses only the α2,3-linkage to
infect cells (Dugan et al., 2005) (Table 1). A prominent role for the
gangliosides GD1b and GT1b has been observed for BKV infection of
kidney cells (Low et al., 2006) (Table 1).
BKV entry into cells is also similar to that of SV40, using caveolae
mediated endocytosis to presumably deliver the virus to the ER for
uncoating (Eash et al., 2004) (Fig. 2). JCV behaves differently than any
of the described polyomaviruses and rather than being internalized
directly into caveolae the virus utilizes clathrin dependent mechan-
isms to infect the cell (Pho et al., 2000) (Fig. 2). Virus entry proceeds
by the normal clathrin dependent pathway to early endosomes
(Querbes et al., 2004) (Fig. 2). Once in the early endosome, however,
the virus is transported to caveosomes in a pH dependent manner
(Querbes et al., 2006). From here the virus is most likely transported
to the ER, presumably the common site of all polyomavirus uncoating
events in the cell.
In addition to utilizing sialic acid as a receptor JCV has been shown
to require the serotonin receptor, 5HT2aR, to infect glial cells
(Fonseca-Elphick et al., 2004) (Table 1). The 5HT2a receptor is
sufﬁcient to confer susceptibility to cells lacking this receptor (HeLa
and HEK293A). Infection of 5HT2aR expressing cells is still neurami-
nidase sensitive indicating a prominent role for cellular carbohydrates
in infection. The 5HT2aR protein contains several potential glycosyla-
tion sites but it is unclear whether the sialic acid moieties responsible
for infection reside on this protein or on other sialic acid containing
molecules such as gangliosides. One group has found that JCV can
infect human brainmicrovascular endothelial cells that lack the 5HT2a
receptor (Chapagain et al., 2007). Infection is very inefﬁcient but the
results indicate that virus infection can proceed by alternative
mechanisms on some cell types.
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with carbohydrate
The polyomavirus capsid consists of 12ﬁve-coordinated and60 six-
coordinated morphological units that assemble into a T=7d icosahe-
dral capsid (Klug, 1965). Icosahedral capsid symmetry allows the virus
to construct a container for its DNA from a large number of identical
subunits, eliminating the need to encode many different components
(Crick and Watson, 1956). Strict icosahedral symmetry, in which all
subunits as well as their interactions with each other are identical, can
only apply to capsids consisting of no more than 60 identical subunits.
Some exceptionally simple isocahedral virus capsids are indeed
constructed from 60 identical subunits and therefore possess strict
icosahedral symmetry (Tsao et al., 1991). However, the need for more
complex structures that can package larger genes as well as internal
proteins requires formany viruses a capsid that cannot be formedwith
such a small number of subunits. Therefore, most viruses, including
polyomaviruses, build larger capsids constructed from multiples of 60
subunits. In these capsids, subunits must be joined in a quasi-
equivalent manner, meaning that they do not form the same contacts
with their neighbors throughout the capsid, but exhibit ﬂexibility or
alternative binding modes to accommodate local symmetry mis-
matches (Caspar and Klug, 1962). The quasiequivalence principle
postulated that the pentavalent and hexavalentmorphological units of
such larger icosahedral capsids were pentamers and hexamers of the
same subunit. In some cases, this has been proven correct, e.g. for
herpesvirus capsids (Zhou et al., 2000). The T=7d icosahedral capsids
of polyomaviruses were therefore also thought to consist of 420
subunits, grouped into 12 pentamers and 60 hexamers of the major
capsid protein VP1 (Finch, 1974). However, the crystal structure of the
mPyV capsid at 22.5 Å resolution revealed that both the ﬁve- and six-
coordinatedmorphological units of the capsid were in fact pentamers,
a surprising result that appeared to challenge the concept of
quasiequivalence as the same pentameric module is able to form
both pentavalent and hexavalent contacts (Rayment et al., 1982). The
crystal structure of SV40 at 3.8 Å resolution, which was determined
almost 10 years later ﬁnally provided the molecular basis for the
unexpected capsid construction of polyomaviruses (Liddington et al.,
1991). It revealed that the interpentamer contacts are primarily
mediated by C-terminal extensions of VP1, termed arms, that protrude
in different directions from each VP1 monomer and contact neighbor-
ing pentamers. Both pentavalent and hexavalent pentamers donate
and accept ﬁve C-terminal arms to tie the capsid together. The VP1
pentamer cores and the contacts between incoming arm and acceptor
monomer are identical throughout the capsid, demonstrating that
the polyomavirus capsid also uses a form of quasiequivalence as the
basis for its construction.Monomeric VP1 is formed by two antiparallel
β-sheets: a sheet formed by strands B, I, D and G (the BIDG sheet)
and a sheet formed by strands C, H, E and F (the CHEF sheet). The two
β-sheets are organized into a jelly-roll fold, a structural motif that is
quite often observed in virus capsid proteins but rare in non-viral
proteins. Each incoming arm adds one strand (J′) to the edge of the
BIDG sheet of amonomer. The J′ strand is then ﬁxed by the N-terminus
of the accepting monomer, which acts as a clamp by adding a short
helix and a ﬁnal β-strand (A) to the sheet next to the J′ strand. The
assembled structure is further stabilized by two calcium ions. These
ﬁndings were conﬁrmed for mPyV and are thought to hold true for the
other members of the polyomavirus family as well because of
conservation of the key contact residues (Stehle et al., 1996; Stehle
et al., 1994).
Structural studies of unassembled, or “free”, pentamers that lack
their C-terminal arms provide insight into one aspect of capsid assem-
bly (Neu et al., 2008; Stehle and Harrison, 1997). The only structural
change between free VP1 and VP1 in the context of the capsid is a
rearrangement at the N-terminus, which forms a helix ﬁxing the
incoming arm in the capsid. In free pentamers, this part of VP1 forms aβ-strand that aligns with the G strand and contacts residues at the
beginning of the C-terminal arm. One likely interpretation of this
ﬁnding is that this arrangement serves to guide the C-terminal arm
away from its own subunit, thereby preventing misassembly of the
polyomavirus capsids.
Receptor binding by mPyV was structurally investigated early on
for whole virions as well as for VP1 pentamers (Stehle et al., 1996;
Stehle and Harrison, 1997; Stehle et al., 1994) as it was known that
mPyV bound α2,3-linked sialic acid (Cahan et al., 1983; Fried et al.,
1981). The sialylated oligosaccharides used as receptor mimics bound
to VP1 in shallow pockets on the outer surface of the pentamers.
These sialylated oligosaccharides were later found to be portions of
the GD1a and GT1b gangliosides, which are the physiologic receptors
for mPyV (Tsai et al., 2003). The same group also identiﬁed the
ganglioside GM1 as a receptor for SV40 (Tsai et al., 2003). The struc-
tural and functional characterization of the interaction between SV40
and GM1 was made possible because a wide variety of glycans were
available for deﬁning receptor speciﬁcity and as the oligosaccharide
portion of GM1 was available in amounts sufﬁcient for structural
analysis (Campanero-Rhodes et al., 2007; Neu et al., 2008). As an
increasing amount of structural information on viral attachment
proteins in complex with sialylated carbohydrate receptors has
become available in recent years, we will focus the remainder of
this chapter on those ﬁndings and their general implications.
Viral attachment to sialic acid
Sialic acids are present on virtually every cell type in higher
vertebrates (Varki, 2008). Sialylation is a terminal modiﬁcation on
glycolipids and glycoproteins, and sialic acids can be attached to a
variety of monosaccharides via different glycosidic linkages. Physio-
logical functions include cell–cell attachment via speciﬁc receptors,
general charge repulsion of blood cells as well as roles in neuronal
plasticity, immune regulation and glomerular ﬁltration (reviewed in
(Varki, 2008). Many pathogens attach to sialic acid-containing
receptors to enter cells, such as a number of viruses as well as
bacterial toxins belonging to the Clostridium neurotoxin and AB5
families.
The most common sialic acid in humans is N-acetyl neuraminic
acid (NeuNAc). It forms a six-membered glycosidic ring, to which
several groups are attached, some in substitution for the typical
hydroxyl groups of carbohydrates: a carboxylate group at the anomeric
carbon C2, an N-acetyl group at the C5 carbon, and a glycerol chain at
carbon C6 (Fig. 4A). The overall structure of NeuNAc is rather rigid. In
solution, the sugar ring prefers the energetically most favorable chair
conformation, positioning its three distinctive groups in three
different directions that serve as “handles” with which attachment
proteins can interact. While the glycerol chain with three freely
rotating bonds is quite ﬂexible, the other two groups possess limited
degrees of rotational freedom.
High-resolution structural information on the interaction of viral
attachment proteins with sialylated carbohydrates is available for the
following systems: Inﬂuenza virus A haemagglutinin (HA) in
complex with oligosaccharides containing α2,3-linked and α2,6-
linked NeuNAc (Eisen et al., 1997; Gamblin et al., 2004; Ha et al.,
2001; Ha et al., 2003; Russell et al., 2006; Sauter et al., 1992; Stevens
et al., 2006; Stevens et al., 2004; Weis et al., 1988), mPyV VP1 with a
fragment of ganglioside GD1a (Stehle and Harrison, 1997), rhesus,
swine and human rotavirus VP8⁎ with methyl-α2,3-sialoside
(Blanchard et al., 2007; Dormitzer et al., 2002a), adenovirus Ad37
ﬁber knob (Ad37) with α2,3- and α2,6-sialyllactose (Burmeister et
al., 2004) and SV40 VP1 with ganglioside GM1 (Neu et al., 2008).
Paramyxoviruses bind to their host cells with their haemagglutinin–
neuraminidase protein that uses the same binding site for attach-
ment to NeuNAc and cleavage of its glycosidic bond (Crennell et al.,
2000). We will, however, focus here on viral proteins that solely
Fig. 4. Sialic acid recognition by viral attachment proteins. (A) Schematic of N-acetyl neuraminic acid. The arrow points to the O2 oxygen that is involved in glycosidic linkages to
adjacent sugars. (B–F) Contacts of NeuNAcwith Inﬂuenza HA (B), Ad37 (C), Rotavirus VP8⁎ (D), mPyV VP1 (E) and SV40 VP1 (F). pdb entries 1hgg (B), 1uxa (C), 1kqr (A, D),1vps (E) and
1bwr (F) were used to create this ﬁgure. NeuNAc is depicted in orange, the protein residues forming hydrogen bonds to NeuNAc are colored green and the residues making van der
Waals contacts are colored grey. The viral surface is shown in grey. This ﬁgure was prepared with PyMol (DeLano Scientiﬁc, Inc.).
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acid binding by catalytically active viral neuraminidases is probably
not directly comparable to binding by attachment proteins, as
neuraminidase function requires high afﬁnity as well as additional
binding energy to distort the sialic acid for catalysis. Neuraminidases
thus feature deeply buried binding sites with a higher number of
speciﬁc contacts than are found in attachment proteins.
Although most of the attachment proteins listed above are not
homologous and are found on unrelated enveloped as well as non-
enveloped viruses, there are some general similarities in the modes of
oligosaccharide binding. First, in all viral complexes, NeuNAc is the
major, and in the case of Ad37 and VP8⁎ the only, point of contact. This
distinguishes these complexes from, for example, bacterial toxins,
which can also recognize sialylated receptors but form more contacts
with carbohydrates attached to sialic acid than with the sialic acid
itself (Fotinou et al., 2001; Merritt et al., 1994; Stenmark et al., 2008).
Second, all viral attachment complexes bind NeuNAc in shallow
depressions rather than deep grooves on the protein surface. The
afﬁnities for these interactions are only in the millimolar range, which
is consistent with the exposed binding surfaces (Burmeister et al.,
2004; Dormitzer et al., 2002b; Eisen et al., 1997; Neu et al., 2008;
Stehle et al., 1996). A relatively low afﬁnity may in fact be crucial for a
productive viral infection as a very tight attachment to the host cell
will prevent progeny virus from spreading. Third, the attachment
protein complexes all feature NeuNAc in its chair conformation, which
is the preferred conformation in solution. Fourth, as detailed in the
next section, there are several parallels in the strategies used by
attachment proteins to bind sialic acid.
The listed similarities observed in complexes of viral attachment
proteins and sialylated receptors do not extend to other proteins that
also bind the same type of receptors, indicating that they do represent
characteristic properties of viral proteins that mediate engagement of
host cell receptors. For example, the low afﬁnity binding by viral
attachment proteins is in contrast to bacterial toxins, which also bind
sialylated oligosaccharides but employ deeper pockets and generally
feature signiﬁcantly higher afﬁnity (Fotinou et al., 2001; Merritt et al.,
1994; Stenmark et al., 2008). In contrast to the numerous binding sites
on viruses, bacterial toxins have only one or at most ﬁve carbohydrate
binding sites, and the interactions between these and cellular
receptors must be sufﬁcient to provide cell entry.
Speciﬁc contacts with sialic acid
The charged carboxylate group of sialic acid is arguably the most
uniquely identiﬁable feature of this carbohydrate when compared to
similar, uncharged structures. It is therefore perhaps not surprising
that all of the viruses or viral proteins investigated here engage this
group. However, they do so by employing two different strategies. The
mPyV and Ad37 form salt bridges from the positively charged side
chains of Arg and Lys residues to the negatively charged carboxylate
group (Figs. 4E and C, respectively). By contrast, the other three
viruses engage the carboxylate group with two parallel hydrogen
bonds. In each case, the carboxylate group accepts two hydrogen
bonds from two speciﬁcally spaced hydrogen bond donors in the
proteins. In the Inﬂuenza HA, SV40 VP1 and Rotavirus VP8⁎
complexes, these are either the hydroxyl groups of Ser and Thr side
chains or backbone amido groups (Figs. 4B, D, E). These parallel
hydrogen bonds also have similar geometry. For each of them, the
angle between the carboxylate C1, the carboxylate O that is engaged
and the hydrogen bond donor approaches 120°.
Recognition of the negatively charged carboxylate group of NeuNAc
alonewould not distinguish it fromothermolecules bearing a negative
charge. The N-acetyl group, situated on the opposite side of the sugar
ring as the carboxylate group, can serve as additional “handle” on
NeuNAc and it provides speciﬁcity by additional favourable contacts
with the correct ligand. TheN5 atom of the N-acetyl group is contactedby a hydrogen bond in each of the complexes. The binding partners are
hydrogen bond acceptors in the protein, such as backbone carbonyl
groups (Figs. 4B–D), the side chain carbonyl group of an Asn residue
(Fig. 4F) or the hydroxyl group of a Tyr side chain (Fig. 4E). The mPyV
VP1 also forms an additional hydrogen bond by an Asn side chain,
which contacts the carbonyl group of the acetyl function. With the
sole exception of mPyV VP1, the binding sites of all proteins also
feature a depression into which the methyl group of the N-acetyl
moiety inserts. This depression is shallow and rather hydrophobic in
the case of Ad37, Inﬂuenza HA and Rotavirus VP8⁎, as it is lined with
hydrophobic side chains (Figs. 4B–D). Interestingly, SV40 VP1 does not
feature such a shallow depression to accommodate the methyl group.
Rather, it has a substantially deeper pocket that is formed by
hydrophobic residues such as Leu65 and Phe75 and lined with
hydrophilic side chains of residues Gln62 and Gln278 at its rim
(Fig. 4F). The natural hosts of SV40 are monkeys, in which N-glycolyl
neuraminic acid (NeuNGc) is the predominant sialic acid. In contrast to
the human NeuNAc, NeuNGc has an additional hydroxyl group
attached to the methyl group. The big, partly hydrophilic and likely
water-ﬁlled cavity in SV40 could likely accommodate the more polar
NeuNGc better than NeuNAc (Campanero-Rhodes et al., 2007), which
might account for its shape.
Even though contacts with the carboxylate and N-acetyl groups are
sufﬁcient to position NeuNAc correctly on the protein surface, most
attachment complexes feature contacts with the polar and ﬂexible
glycerol moiety. This group protrudes away from the protein in the
mPyV VP1 and Ad37 complexes (Figs. 4C and E), but is recognized by a
number of contacts in the other complexes. There are hydrogen bonds
to O8 and O9 by each of SV40 VP1, Inﬂuenza HA and Rotavirus VP8⁎
that are formed by Ser, Tyr and Arg side chains (Figs. 4B, D, F). In
addition, the glycerol chain lies in a shallow pocket in all of these
complexes and makes van der Waals contacts to residues that confer
shape speciﬁcity.
In summary, while all of the binding sites recognize the
carboxylate group and form a hydrogen bond to the N-acetyl group,
only some (SV40 VP1, Inﬂuenza HA and Rotavirus VP8⁎) contact the
glycerol chain both by hydrogen bonds and shape complementarity. In
addition, most also feature a depression that accommodates the
methyl group of the N-acetyl moiety. Since all binding surfaces are
exposed, the interactions determining NeuNAc binding lie in the
rather polar environment of the protein surface. The polar interactions
are therefore probably quite weak. Hydrogen bonds between sialic
acid and protein atoms can be replaced by contacts between water
molecules and protein atoms without much difference in energy. Salt
bridges in aqueous solution also possess less energy than salt bridges
that are located in a partially hydrophobic, solvent-inaccessible
environment. Likewise, the non-polar van der Waals interactions
between carbohydrate and protein are also not very strong as such
interactions increase in strength with the area of surface buried in the
contact. Most of the contacts described above exclude rather small
areas from solvent compared to the extensive interfaces found in
protein–protein complexes.
The observed, relatively weak interactions are consistent with the
experimentally-determined millimolar afﬁnities for the protein–
glycan complexes. The shallow binding sites of attachment proteins
do not exclude binding of incorrect ligands by steric clashes. Instead,
speciﬁcity is provided by favorable interactions that are spaced in a
way that only the correct ligand can engage in all contacts. In the case
of Inﬂuenza HA, mPyV VP1 and SV40 VP1, sialic acid by itself is not
sufﬁcient for binding, but additional sugars are also needed for the
interaction.
How do viruses discriminate among sialic acids in different contexts?
Two of the viruses mentioned before, Rhesus Rotavirus and Ad37,
appear to bind NeuNAc relatively indiscriminately, although it is
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mPyV, SV40 and different strains of inﬂuenzaviruses, however, have
distinct speciﬁcities for the structural contexts of the sialic acid.
mPyV VP1 binds carbohydrates containing a NeuNAc-α2,3-Gal
motif that is unbranched at the Gal position (Cahan et al., 1983). The
Gal moiety is recognized by a hydrogen bond between the backbone
carbonyl group of Gly78 and the distinctive axial O4 hydroxyl group of
Gal (Stehle and Harrison, 1997). The lack of a side chain in Gly78 also
confers binding speciﬁcity since the presence of even a small side
chain in this position would cause sterical clashes with the Gal and
abolish binding. The architecture of the binding site accepts only one
conformation of the NeuNAc-α2,3-Gal glycosidic linkage. This con-
formation is stabilized by an internal hydrogen bond and also occurs
in solution, but it could not be adopted by compounds that are
branched at the Gal residue due to steric clashes.
SV40 VP1 possesses quite narrow speciﬁcity for the oligosacchar-
ide part of the ganglioside GM1, which is a branched compound of the
following structure: Gal-β1,3-GalNAc-β1,4-[NeuNAc-α2,3-]-Gal-β1,4-
Glc. While SV40 still binds the same compound with NeuNGc
substituted for NeuNAc, binding is abolished if one of the terminal
sugars, i.e. Gal or NeuNAc, are removed or if one of them bears an
additional sugar moiety (Campanero-Rhodes et al., 2007; Neu et al.,
2008). Both the Gal-β1,3-GalNAc and NeuNAc branches directly
contact the protein, providing binding afﬁnity. The core structure of
GM1, i.e. the branching Gal with GalNAc and NeuNAc attached to
neighboring atoms is sterically constrained as clashes between GalNAc
and NeuNAc could occur in many conformations of the glycosidic
linkages. The moiety adopts one dominant conformation in solution
(Poppe et al., 1994), which is bound by SV40 VP1. Speciﬁcity therefore
arises from SV40 recognizing the correct placement of the two binding
arms by a rigid spacer.
Different strains of Inﬂuenza A virus infect different species
because their HA molecules bind sialic acid in different contexts.
The adaptation of avian HAs to human hosts occurs by a switch in
binding speciﬁcity from avian-like α2,3-sialylated glycans to the
longer α2,6-sialylated glycans that are present in the upper
respiratory tract epithelia of humans (Russell et al., 2006; Skehel
and Wiley, 2000; Stevens et al., 2006; van Riel et al., 2007). NeuNAc is
bound in the same orientation and by the same residues of both avian
and human HAs so that speciﬁcity is conferred by the residues in
contact with additional monosaccharides. Recent data indicate that
the different glycan types are not discriminated by contacts with the
sugar residue to which the NeuNAc is linked, but that the different
overall topology of the glycans is recognized (Chandrasekaran et al.,
2008). Given the preferred torsion angles of the NeuNAc-α2,3-Gal-
β1,3/4-GlcNAcmotif typical of the recognizedα2,3-linked glycans, the
Gal-β1,3/4-GalNAc part is fairly linear and can occupy the space
delineated by a cone with NeuNAc at its tip. Sugar moieties farther
away from the NeuNAc mostly do not interact with the protein in this
conformation. The glycans containing α2,6-linked NeuNAc, for which
NeuNAc-α2,6-Gal-β1,4-GlcNAc is typical, can also adopt this cone-
shaped topology. However, these also sample a topology, in which the
Gal is relatively ﬁxed with respect to NeuNAc and there is a kink at the
Gal position, forcing the GlcNAc and subsequent sugars to point back
towards the protein. The space that can be sampled by the glycan
therefore resembles an umbrella, with NeuNAc-α2,6-Gal as the stick
and the rest of the glycan as the umbrella. For α2,6-linked
trisaccharides that can sample both cone- and umbrella-shaped
topologies, the cone-shaped one is preferred. However, the longer
α2,6-linked glycans that confer infectivity in humans prefer the
umbrella-shaped topologies, leading to additional contacts with the
protein. If the HA of an inﬂuenza strain cannot accommodate these
long, umbrella-shaped α2,6-linked glycans, it cannot spread in
humans (Chandrasekaran et al., 2008).
Several of the structural and functional studies described above
required the use of correct ligands. The use of model glycans such asα2,6-linked sialyllactose would not have revealed the difference in
topology that is crucial for glycan recognition by HAs, as these short
glycans do not adopt the umbrella shape that is bound by human
inﬂuenzaviruses. In the case of SV40, only the correct GM1 receptor
bound to the protein. Smaller, unbranched components of the GM1
structure would not have given insight into SV40 receptor binding as
they do not bind with detectable afﬁnity (Neu et al., 2008). Several
other viruses, e.g. strains of coronavirus and reovirus, bind sialylated
glycans, but structural information about these interactions is
currently lacking. The availability of complex glycans and the use of
glycan screens to deﬁne binding speciﬁcity have proven of great
importance and will undoubtedly advance the understanding of
glycan binding by these other viruses.
Discussion
The original studies describing polyomavirus host cell interactions
depicted infection as involving a series of discrete steps that included
virus adsorption, virus entry into membrane bound organelles, and
virus trafﬁcking by sequential membrane fusion and ﬁssion events.
Although there was controversy regarding whether these viruses
could penetrate the nuclear envelope intact an early pivotal study
demonstrated that the virus capsid only penetrates the outer nuclear
envelope. Recent studies on these viruses describe largely the same
series of steps but in signiﬁcantly more detail. We now know and
appreciate that the majority of these viruses recognize speciﬁc
linkages of sialic acid on gangliosides and glycoproteins. These viruses
also recognize other cellular components such as the 5HT2a receptor
for JCV, α4β1 integrin for mPyV, and the MHC class I protein for SV40,
likely as part of a receptor complex with gangliosides or other sialic
acid containing structures. There are clear cell type speciﬁc and viral
strain differences that determine what components of the receptor
complex are required to initiate infection. Once bound to cells all of
these viruses induce molecular signals that initiate infectious entry.
The mPyV, SV40, and BKV all infect cells by caveolae dependent
endocytosis. Non-caveolar cholesterol dependent mechanisms can
also be exploited by some of these viruses depending on cell type.
Downstream of both caveolae and raft dependent mechanisms the
viruses trafﬁc to a pH neutral caveosome that lacks markers of other
cellular organelles. High resolution video microscopy of virus entry
has found that these viruses are trafﬁcked out of the caveosomes in
elongated tubular structures that fuse with the ER membrane. This
trafﬁcking step is dependent on microtubules. The human poly-
omavirus, JCV, appears to be an exception and rather than utilizing
caveloae to enter cells this virus exploits clathrin dependent
mechanisms to initially trafﬁc to early endosomes. In the early
endosomes JCV is found to be tightly opposed to the inner leaﬂet of
the endosome and in a pH and Rab5 dependent step trafﬁcs from the
early endosome to caveosomes. At this point the virus likely follows
the fate of other polyomaviruses and travels to the ER. Once in the
ER the viruses take advantage of protein disulﬁde isomerases
to rearrange their capsid structure. In the case of SV40, PDI and
ERp57 rearrange the 12 ﬁve-coordinated VP1 pentamers. The now
misfolded structure is recognized by components of the ERAD
pathway (Derlin 1, SelL1) and exported to the cytosol. Calcium levels
in the cytosol of resting cells are signiﬁcantly lower (0.1 μM) than
levels in the ER (100–400 μM). As calcium is required to stabilize
polyomavirus virions the low levels of calcium encountered as the
destabilized virus exits the ERAD pathway are likely sufﬁcient to
further distort and disassemble the virion and prepare it for transport
through the nuclear pore. In the case of mPyV a novel PDI like protein,
ERp29 acts to unfold VP1 exposing a protease sensitive site in the C-
terminal arm of the protein. Once cleaved the destabilized particle
can insert into a lipid membrane. The virus may directly escape the ER
via this mechanism or it might utilize the retrotranslocator Derlin 2 as
inhibition of this protein reduces mPyV infection. It is likely that the
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but this has not been formally demonstrated.
Early structural studies on mPyV and SV40 challenged the quasi-
equivalence theory of capsid assembly as therewere 72VP1 pentamers
arranged that formed both pentavalent and hexavalent contacts.
Subsequent high resolution structural studies provided the molecular
basis for this unexpected capsid construction. It revealed that the
interpentamer contacts are primarily mediated by C-terminal exten-
sions of VP1, termed arms, that protrude in different directions from
each VP1 monomer and contact neighboring pentamers. Both pen-
tavalent and hexavalent pentamers donate and accept ﬁve C-terminal
arms to tie the capsid together. The VP1 pentamer cores and the
contacts between incoming arm and acceptor monomer are identical
throughout the capsid, demonstrating that the polyomavirus capsid
also uses a form of quasiequivalence as the basis for its construction.
Recent high resolution structural studies on viral capsid proteins in
complex with receptor fragments has provided a detailed picture of
how these viruses engage this component of the receptor complex.
This level of detail may provide the basis for the design of small
molecular weight compounds capable of antagonizing polyomavirus
host cells receptor interactions and may in time lead to novel
therapeutic approaches to treat patients with polyomavirus induced
disease.
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